The scholarly study included more than 20,000 people, aged 18 and older, in British households who were randomly assigned to use PRIMIT or to a control group that did not use the website. Over 16 weeks of monitoring, 51 % of people in the PRIMIT group had at least one respiratory infection, weighed against 59 % of those in the control group. That means those in the PRIMIT group had a 14 % lesser risk, the researchers said. Those in the PRIMIT group experienced a 20 % reduce risk of catching a flu-like illness. In addition they had 10 % to 15 % fewer doctor appointments and antibiotic prescriptions, the study found.The full total results of the study, led by the National Vision Institute-funded Research of the Ocular Problems of AIDS Study Group, were also published on-line in the American Journal of Ophthalmology. ‘With HIV and AIDS patients living much longer than previously, they are at an elevated risk of developing several age-related diseases at a youthful age than HIV-uninfected people including coronary disease and diabetes,’ said Douglas A. Jabs, MD, MBA, Professor of Ophthalmology and Medication at the Icahn College of Medicine at Mount Sinai, and the lead author of the new research.